Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016692 |
---|---|
Receipt number | R000019359 |
Scientific Title | Adapalene vs. Placebo as Prophylaxis for anti-EGFRs-induced Acne-like rash, a Randomized left-right Comparative Evaluation (APPEARANCE) |
Date of disclosure of the study information | 2015/05/25 |
Last modified on | 2019/12/23 23:19:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/03/03 12:50:44 | ||
2 | Update | 2015/03/23 14:00:33 | Date of disclosure of the study information |
|
3 | Update | 2015/04/23 12:37:40 | Interventions/Control_1 |
|
4 | Update | 2015/04/23 12:41:06 | Institutions Date of disclosure of the study information |
|
5 | Update | 2016/03/08 13:28:34 | Recruitment status Anticipated trial start date |
|
6 | Update | 2016/04/12 13:52:06 | Last name of contact person Division name Name of person sending information Division name Name of primary person or sponsor Institute Department Organization |
|
7 | Update | 2017/03/08 12:52:13 | Recruitment status |
|
8 | Update | 2017/04/18 13:20:10 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name Last name of contact person Division name Name of person sending information Division name |
|
9 | Update | 2017/04/18 13:20:42 | Recruitment status |
|
10 | Update | 2017/05/29 13:03:10 | Recruitment status |
|
11 | Update | 2018/03/06 13:47:38 | Recruitment status |
|
12 | Update | 2019/12/13 16:37:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
13 | Update | 2019/12/18 22:36:30 | Date of IRB Last follow-up date |
|
14 | Update | 2019/12/23 22:28:15 | Recruitment status |
|
15 | Update | 2019/12/23 23:19:55 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |